Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 1 | $10,990,762 |
Sells | 121 | $9,707,733 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
10 Nov 2022 17:29 | ALVR | Allovir Inc | VAN BEEK JEROEN B | Chief Commercial Officer | 08 Nov 2022 | Sale | 299 | 8 | 2,392 | D |
26 Oct 2022 16:15 | ALVR | Allovir Inc | SINHA VIKAS | See Remarks, 10% | 20 Oct 2022 | Sale A | 1,449 | 9.3607 | 13,564 | D |
26 Oct 2022 16:15 | ALVR | Allovir Inc | VAN BEEK JEROEN B | Chief Commercial Officer | 20 Oct 2022 | Sale A | 1,070 | 9.3607 | 10,016 | D |
26 Oct 2022 16:15 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 20 Oct 2022 | Sale A | 345 | 9.3607 | 3,229 | D |
26 Oct 2022 16:15 | ALVR | Allovir Inc | ATILLASOY ERCEM | See Remarks | 21 Oct 2022 | Sale A | 1,527 | 8.4843 | 12,956 | D |
26 Oct 2022 16:15 | ALVR | Allovir Inc | ATILLASOY ERCEM | See Remarks | 20 Oct 2022 | Sale A | 568 | 9.3607 | 5,317 | D |
26 Oct 2022 16:15 | ALVR | Allovir Inc | MILLER EDWARD | General Counsel | 20 Oct 2022 | Sale A | 553 | 9.3607 | 5,176 | D |
24 Oct 2022 18:24 | ALVR | Allovir Inc | MILLER EDWARD | General Counsel | 19 Oct 2022 | Sale | 553 | 9.3607 | 5,176 | D |
24 Oct 2022 18:25 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 24 Oct 2022 | Sale | 2,000 | 8.1345 | 16,269 | D |
24 Oct 2022 18:25 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 21 Oct 2022 | Sale | 11,334 | 8.4524 | 95,800 | D |
24 Oct 2022 18:25 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 19 Oct 2022 | Sale | 345 | 9.3607 | 3,229 | D |
24 Oct 2022 18:26 | ALVR | Allovir Inc | VAN BEEK JEROEN B | Chief Commercial Officer | 19 Oct 2022 | Sale | 1,070 | 9.3607 | 10,016 | D |
24 Oct 2022 18:28 | ALVR | Allovir Inc | SINHA VIKAS | See Remarks, 10% | 19 Oct 2022 | Sale | 1,449 | 9.3607 | 13,564 | D |
24 Oct 2022 18:23 | ALVR | Allovir Inc | ATILLASOY ERCEM | See Remarks | 20 Oct 2022 | Sale | 1,527 | 8.4843 | 12,956 | D |
24 Oct 2022 18:23 | ALVR | Allovir Inc | ATILLASOY ERCEM | See Remarks | 19 Oct 2022 | Sale | 568 | 9.3607 | 5,317 | D |
21 Oct 2022 21:30 | ALVR | Allovir Inc | HALLAL DAVID | Director , 10% | 19 Oct 2022 | Sale | 600,000 | 8.45 | 5,070,000 | I |
30 Sep 2022 16:05 | ALVR | Allovir Inc | HALLAL DAVID | Director , 10% | 29 Sep 2022 | Sale | 400,000 | 7.3523 | 2,940,920 | I |
06 Sep 2022 16:17 | ALVR | Allovir Inc | VAN BEEK JEROEN B | Chief Commercial Officer | 02 Sep 2022 | Sale | 493 | 7.8888 | 3,889 | D |
06 Jul 2023 17:00 | ALVR | Allovir Inc | SINHA VIKAS | See Remarks, 10% | 05 Jul 2023 | Sale | 2,983 | 3.0451 | 9,084 | D |
06 Jul 2023 17:00 | ALVR | Allovir Inc | BRAINARD DIANA | Chief Executive Officer | 05 Jul 2023 | Sale | 5,275 | 3.0451 | 16,063 | D |
28 Jun 2023 17:17 | ALVR | Allovir Inc | GILEAD SCIENCES, INC. | 10% | 27 Jun 2023 | Purchase | 2,930,870 | 3.75 | 10,990,762 | D |
13 Jun 2023 17:00 | ALVR | Allovir Inc | HAGEN BRETT R | Chief Accounting Officer | 09 Jun 2023 | Sale | 5,045 | 5.6398 | 28,453 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)